Sloan Kettering's cozy deal with start-up ignites a new uproar

Paige.AI promised to transform how cancer is diagnosed with application of AI and health care. Their advantage, though, was access to 25 million patient tissue slides through Sloan Kettering as well as investors from the cancer center holding stake in the start-up. The arrangement has sparked outrage and caused resignations, The New York Times reports. 

from Business News https://ift.tt/2Dt6dkS